Resumption of HIV antigen production during continuous zidovudine treatment.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000276:immunology; D000956:Antigens, Viral / Q000096:biosynthesis*; D000998:Antiviral Agents / Q000627:therapeutic use*; D006678:HIV / Q000276:immunology*; D006801:Humans; D013936:Thymidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015215:Zidovudine
D000956:Antigens, Viral; D000998:Antiviral Agents; D015215:Zidovudine; D013936:Thymidine